Over the past 12 months we have investigated both the GIFT technique and DIPI combined with intrauterine insemination (lUI) and our initial results in the first year of a new fertility clinic are presented.
Subjects and methods
Sixty-nine patients (93 cycles) who had previously been fully investigated for infertility were entered into the programme. An assessment laparoscopy within the last year in order to establish tubal patency and the normality of the pelvis was an important prerequisite. Thirty-three patients (51 cycles)entered the DIPIJIUI programme and 36 patients (42 cycles) entered the GIFT programme. Full details of the patients can be seen in Table 1 . The individual cause of infertility was similar in both groups with the majority of patients having unexplained infertility. Nine patients (11 cycles) who initially had GIFT, which was unsuccessful, went on and had DIPIJIUI (13 cycles) and 3 patients (6 cycles) who initially had DIPIJIUI went on and had a GIFT cycle (3 cycles).
GIFT method
Ovarian superovulation treatment, similar to that employed for IVF, using clomiphenecitrate (Serophene, Serono Laboratories) and intramuscular (1M) human menopausal gonadotrophin (HMG, Pergonal, Serono Laboratories) was given to all patients. Clomiphene citrate 100 mg was given on days 2-6, with day 1 being the first day of menses. The dose of HMG, titrated according to follicular development, was monitored with serial pelvic ultrasound. Treatment was continued until at least two follicleshad achieved a diameter of 16 mm and then 7500 IU of human chorionic gonadotrophin (BCG Profasi, Serono Laboratories) was given intramuscularly. A laparoscopy was undertaken 32-34 h later after ultrasound had confirmed that ovulation had not occurred.
Laparoscopy 
Summary
We present our early experience with gamete intrafallopian transfer (GIFT) and direct intraperitoneal insemination (DIPI) combined with intrauterine insemination (IUD, two recently described methods of assisting conception in patients with patent fallopian tubes. Sixty-nine patients (93 cycles) were entered into the study. Thirty-three patients (51cycles) entered the DIPIJIUI programme and 36 patients (42 cycles)entered the GIFT programme. The mean age, duration and aetiology of infertility were similar in both groups. In the GIFT programme 12 pregnancies occurred, which is a 29%pregnancy rate per cycleand a 33% pregnancy rate per patient. In the DIPIJIUI programme only 3 pregnancies occurred, being a 6% pregnancy rate per cycle and a 9%pregnancy rate per patient. WIth the live birth rate ofin vitro fertilization (IVF) being 12% per embryo transfer, we concludethat GIFT is more successful than either DIPIJIUI or IVF in patients with patent fallopian tubes. Further controlled studies are required to assess the future role of DIPIJIUI in clinical practice.
Introduction
Attempts at in vitro fertilization (IVF) and embryo transfer (ET) in humans started in the early 1960s with the first successful human pregnancy and birth after IVF being reported by Steptoe and Edwards in 1978 1 • IVF was originally described for patients with severely damaged or absent tubes. More recently the use of IVF has been extended to the treatment of couples with infertility of different causes. The second report of the Voluntary Licensing Authority for Human In Vitro Fertilization and Embryologyreported the IVF pregnancy rates for the UK in 1985 with an 8.5% live birthrate per treatment cycle and a 12%pregnancy rate per embryo transfer. Recently Asch 3 • 4 has pioneered a new technique of gamete intrafallopian transfer (GIFT) in which gametes are introduced into the healthy ampulla of the fallopian tube at the time of laparoscopy or minilaparotomy for in vivo fertilization. The first pregnancy achieved with this technique ended successfully in a twin pregnancy. Continuing success has been reported in single units" and also in a large multicentre study organized by Asch". The early results suggest a pregnancy rate of 35%, in selected patients. The GIFT technique requires an anaesthetic but alternative, less invasive methods are now available. Direct intraperitoneal sperm insemination (])IPI), an outpatient procedure, was first described by Forrler et aU and in two recent series B • 9 a pregnancy rate per cycle has varied between 14 and 18%. 
Results
The results of the patients having GIFT and DIPI are shown in Tables 2 and 3 . Pregnancy was confirmed by the ultrasound demonstration of intrauterine pregnancy with a fetal heart.
In the GIFT group 12 pregnancies occurred, being a 29% pregnancy rate per cycle and a 33% pregnancy rate per patient. In the DIPIIIUI group three pregnancies occurred, being a 6% pregnancy rate per cycle and a 9% pregnancy rate per patient.
In the GIFT group the characteristics of those patients who became pregnant were similar to those of the group as a whole but all the DIPIIIUI occurred in couples with male pathology and a lower duration of infertility than the group as a whole.
The mean age of the GIFT pregnancy group was 33 years (range 23-42) and the mean duration of infertility 5.8 years (range 1.5-15). The mean age of the DIPI pregnancy group was 34 years (range 30-37) and mean duration of infertility 3.7 years (range 3-5 years). The average number of ampoules of HMG used to stimulate superovulation in the GIFT series was 14 (range 8-31), with the GIFT pregnancy group having on average 13 ampoules (range 10-20).
On average 9 ampoules (range 0-36) of HMG was used in the DIPIIIUI group. However, this included 7 cycles in patients due to have GIFT but who ovulated the morning of the procedure and therefore had DIPIIIUI. In these 7 cycles one pregnancy occurred. Two pregnancies occurred in patients whose primary form of treatment was DIPIIIUI. In both, no HMG was used and only clomiphene citrate was required to stimulate ovulation.
DIPIlIUI was performed in 13 cycles in patients who had had a previous failed GIFT; no pregnancies resulted. Three GIFT cycles followeda previous failed DIPIIIUI cycle and one pregnancy occurred. 
DIPlflUI method
Ovulation was induced using clomiphene citrate and HMG, if required, with follicular development being monitored by ultrasound and 7500 XU of HCG given when two follicles reached a diameter of 16 mm. Seven cycles of DIPI were performed (4 patients) on individuals who had been following the protocol for GIFT but on the morning of the GIFT had ovulated. The DIPIIIUI procedure was performed 36 h after the HCG injection. The sperm was prepared by the method already described in the GIFT section. The patient was placed in a lithotomy position and a Cusco's speculum introduced and the cervix identified. This was cleansed with normal saline and a Wallace catheter introduced into the uterine cavity. 0.5-1 ml of prepared sperm (20-60 x l()6/ml)was then injected. The speculum was then adjusted 80 that the posterior fornix could be identified. A 21 gauge needle was introduced through the posterior fornix into the Pouch of Douglas. Aspiration of peritoneal pneumoperitoneum. The ovary was stabilized by grasping the ovarian ligament with an atraumatic forceps. A double lumen needle was used which enabled Hepes buffered culture medium to be injected through one lumen with aspiration of the fluid through the other. A foot operated pump allowed the operator complete control of the procedure.
Oocytes, with their cumulus masses, were identified in the aspirated fluid and placed into a culture dish containing Earles medium supplemented with 50% patient or donor serum and antibiotics. After evaluation for their maturity according to their size, degree of expansion and stickiness of the cumulus mass, the oocytes were stored in an incubator with 5% CO 2 and air at 37°C until transfer.
Semen samples were obtained about 1.5 h before laparoscopy. Specimens were allowed to liquefy (up to 30 min) and a volume of semen (0.5-1 ml depending on the quality) was added to 4 ml of Earles medium with 10%patient or human serum albumin (HSA)and antibiotics. These were gently mixed and centrifuged at 600 g for 10 min. The supernatant was discarded and a further 2 ml of Earles with 10% serum or HSA was added to the pellet, mixed and centrifuged for a further 10 min at 600 g. The supernatant was discarded and 0.5-1 ml of medium layered onto the pellet for about 30 min to allow the sperm to swim up. The volume was adjusted to 100 000 sperm/10 #1. The sample was then incubated at 37°C with 5% CO 2 until transfer.
For gamete transfer an embryo transfer catheter was used with a Hamilton syringe. The catheter was filled with two oocytes in 10-15 #1 of 50% serum, 5 #1 of air and finally 20 #1 of motile sperm (200 000 sperm) in 10% serum.
The loaded catheter, under sterile conditions, was then carried to the operating room and passed down the trocar of the aspirating needle and introduced through the fimbrial end of the tube to a distance of 15-20 mm. The contents, with gametes, were gently introduced into the ampulla. The catheter was withdrawn and checked microscopically to ensure that the gametes had been replaced. The same procedure was then repeated for the other tube. The patient was allowed home the same day. The serum HCG level was measured 12 days post transfer and if positive an ultrasound scan was carried out at 6 weeks to confirm a pregnancy.
Of the 12 GIFT pregnancies, there were 2 miscarriages (17%), and one set of twins. Two have delivered and 7 pregnancies are ongoing without any complications. There were no ectopic pregnancies. Of the 3 DIPI pregnancies, there was one miscarriage and a set of twins (delivered).
Fifteen cycles of GIFT (28%)were abandoned before laparoscopy. This was due to ovulation in 7 cycles before the morning ofthe operation and 8 cycles where stimulation was inadequate.
Discussion
The results of this study support previous findings 4 -6 that GIFT is successful in producing pregnancies in couples with long-term infertility in the presence of patent tubes. The technique is more physiological than IVF in cases where tubal patency has been confirmed, thus allowing normal gamete transport and presenting a favourable milieu for early embryonic development. In the study follicular development was monitored by sonography alone although other groups5 include biochemical measurements. Laufer et al. 10 conclude that ultrasound monitoring of follicular growth should be coupled with oestradiol and LH assays. We are at present investigating the feasibility of including biochemical measurement in our programme. Although this may increase our rate of abandoned cycles it will perhaps increase our conception rate per completed cycle. Pre HCG endogenous LH release has caused 7 GIFT cycles to be abandoned due to ovulation prior to the timed procedure. In order to suppress endogenous gonadotrophin release and preoperative ovulation the use of LHRH analogues has been proposed. The isolation of the ovary by the use of analogues may reduce the number of cancelled cycles, increase conception rate and allow cycles to be manipulated around a 5 day working week. In the GIFT series the oocytes were graded using a light microscope (magnificationx25) and the most mature oocytes replaced. Asch!' grades oocytes with a differential interference contrast Normanski Optics and has demonstrated that only oocytes of grade 4 (dispersed cumulus oophorusand corona radiata but no visible polar body) or grade 5 (well dispersed cumulus oophorus and corona radiata and the presence of the first polar body)when replaced went on to a successful pregnancy by GIFT. The role of in vitro maturation of oocytes before replacement is now being investigated.
DIPIIIUI is a much simpler technique than either GIFT or IVF but our initial optimism" has not been supported by this study. In our study we combined lUI with DIPI and it is thus impossible to draw any firm conclusions as to the benefit of DIPI. In order to fully assess the efficiency of DIPI it must be compared alone against lUI. However, although the success rate of DIPIllUI is much lower than our GIFT programme it may become an accepted method of treatment in units that do not have the facility to perform GIFT or IVF.
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It has been argued that superovulation alone may be the important component of GIFT. Although our series is small it is interesting to note that in the 7 superstimulated cycles with ovulation prior to GIFT and where DIPIllUI was subsequently performed, one pregnancy occurred. We did not superovulate our DIPIIIUI group to the same extent and in the 2 pregnancies that occurred clomiphene citrate alone had been used to induce ovulation. Asch (personal communication) in his standard work up treats patients for 3 cycles by superovulation and AIH and has a success rate of around 9%. This area needs to be fully investigated and a controlled study established in order to compare superovulation against other methods of assisted conception. GIFT and DIPI being dependent on in vivo fertilization, may be more acceptable to certain religious and cultural groups as the ethical problem of in vitro fertilization is avoided and no possibility of embryo research exists.
We conclude that GIFT appears a superior method of treating patients with patent tubes than DIPIIIUI and IVF. Our results ofDIPIIIUI are comparable with those of IVF but a much larger study is required in order to select whether superovulation or IUIIDIPI plays the important role in assisting conception.
